SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-028225
Filing Date
2019-11-27
Accepted
2019-11-27 16:09:05
Documents
2
Period of Report
2019-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1632
2 EX-24 DOCUMENT attachment1.htm EX-24 4743
  Complete submission text file 0000899243-19-028225.txt   8092
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PROTEOSTASIS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 500 BOSTON MA 02135
Business Address
Chowdhury Badrul A. (Reporting) CIK: 0001776662 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32157 | Film No.: 191257934